White-coat hypertension: new insights from recent studies.

> Two statisticians meet . > > -How do you do? > > -How do I do? Compared to whom? > > — Anonymous Thomas Pickering coined the term white-coat hypertension to denote individuals who were not on treatment for hypertension but who had elevated office blood pressure and normal daytime blood pressure measured with ambulatory blood pressure monitoring (ABPM). Clearly, these individuals would be at low cardiovascular risk.1 The traditional definition of white-coat hypertension is based, therefore, on an elevated office blood pressure with a normal blood pressure during the awake period with ABPM. However, because of the contribution of asleep blood pressure as a predictor of outcome, it seems counterproductive to exclude this period from consideration. The most recent European guidelines2 propose, therefore, an alternative definition of white-coat hypertension, which encompasses subjects with office systolic/diastolic blood pressure readings of ≥140/90 mm Hg and a 24-hour blood pressure <130/80 mm Hg. The purpose of this review is to provide new insights into the characteristics, definitions, and cardiovascular risk assessment in persons with white-coat hypertension, and it will be limited primarily to ABPM with a primary focus on prospective studies. ### Prevalence and Diagnosis White-coat hypertension occurs in 15% to 30% of subjects with an elevated office blood pressure,2,3 and the phenomenon is reasonably reproducible.2,4 Although there are no pathognomonic diagnostic features of white-coat hypertension, this condition occurs more frequently in women, older adults, nonsmokers, recently diagnosed patients with hypertension with a limited number of conventional blood pressure measurements in the office setting who have mild hypertension, pregnant women, and subjects without evidence of target organ damage.2,5,6 The misdiagnosis of subjects with white-coat hypertension as being truly hypertensive can result in them being penalized for employment and insurance rating, as well as being prescribed unnecessary lifelong treatment with potential side …

[1]  Geoffrey A Head,et al.  European Society of Hypertension position paper on ambulatory blood pressure monitoring. , 2013, Journal of hypertension.

[2]  Jeroen J. Bax,et al.  2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.

[3]  E. Lakatta,et al.  White Coat Hypertension Is More Risky Than Prehypertension: Important Role of Arterial Wave Reflections , 2013, Hypertension.

[4]  J. Banegas,et al.  Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs , 2012, Journal of hypertension.

[5]  Luana Colloca,et al.  Nocebo effects, patient-clinician communication, and therapeutic outcomes. , 2012, JAMA.

[6]  E. O’Brien,et al.  Significance of WhiteCoat Hypertension in Older Persons With Isolated Systolic Hypertension , 2012 .

[7]  Jonathan Mant,et al.  Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study , 2011, The Lancet.

[8]  R. Agarwal,et al.  Toward a definition of masked hypertension and white-coat hypertension among hemodialysis patients. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[9]  J. Banegas,et al.  Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring , 2011, Hypertension.

[10]  F. Cuccurullo,et al.  Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. , 2011, American journal of hypertension.

[11]  B. Peretz.  The white coat. , 2010, Refu'at ha-peh veha-shinayim.

[12]  P. D. Leeuw,et al.  Variable hypertension and latent diabetes: two of a kind? , 2009 .

[13]  G. Mancia,et al.  Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension , 2009, Journal of hypertension.

[14]  G. Mancia,et al.  Long-Term Risk of Sustained Hypertension in White-Coat or Masked Hypertension , 2009, Hypertension.

[15]  G. Bakris,et al.  Resistant hypertension: an overview of evaluation and treatment. , 2008, Journal of the American College of Cardiology.

[16]  P. Palatini,et al.  Increase in Carotid Intima-Media Thickness in Grade I Hypertensive Subjects: White-Coat Versus Sustained Hypertension , 2008, Hypertension.

[17]  G. Tsivgoulis,et al.  Factors influencing white-coat effect. , 2008, American journal of hypertension.

[18]  J. Staessen,et al.  Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. , 2007, Blood pressure monitoring.

[19]  J. Staessen,et al.  Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7030 individuals , 2007, Journal of hypertension.

[20]  R. Townsend,et al.  Comparison of Pulse Wave Analysis Between Persons With White Coat Hypertension and Normotensive Persons , 2007, Journal of clinical hypertension.

[21]  Michael Bursztyn,et al.  Reproducibility of white-coat and masked hypertension in ambulatory BP monitoring. , 2007, International journal of cardiology.

[22]  Ryusuke Inoue,et al.  Detection of carotid atherosclerosis in individuals with masked hypertension and white-coat hypertension by self-measured blood pressure at home: The Ohasama Study , 2007, Journal of hypertension.

[23]  J. Staessen,et al.  Progression to hypertension in the non-hypertensive participants in the Flemish Study on Environment, Genes and Health Outcomes , 2006, Journal of hypertension.

[24]  Roberto Sega,et al.  Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure , 2006, Hypertension.

[25]  J. Staessen,et al.  Compared With Whom?: Addressing the Prognostic Value of Ambulatory Blood Pressure Categories , 2006, Hypertension.

[26]  W. Elliott.  White-Coat Hypertension as a Risk Factor for the Development of Home Hypertension: The Ohasama Study , 2006 .

[27]  J. Schwartz,et al.  Short- and Long-Term Incidence of Stroke in White-Coat Hypertension , 2005, Hypertension.

[28]  Gudrun Wacker.  Similarities and Differences , 2005 .

[29]  A. Stanton,et al.  Determinants of white-coat hypertension , 2004, Blood pressure monitoring.

[30]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[31]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[32]  J. Staessen,et al.  Properly defining white coat hypertension. , 2002, European heart journal.

[33]  D. Levy,et al.  Impact of high-normal blood pressure on the risk of cardiovascular disease. , 2002, The New England journal of medicine.

[34]  G. Parati,et al.  Task Force II: Blood pressure measurement and cardiovacular outcome , 2001, Blood pressure monitoring.

[35]  Daniel Levy,et al.  Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study , 2001, The Lancet.

[36]  J. Schwartz,et al.  Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. , 2001, Journal of the American College of Cardiology.

[37]  P. Palatini,et al.  Independent predictors of isolated clinic (`white-coat') hypertension , 2001, Journal of hypertension.

[38]  K. Kario,et al.  White-coat hypertension or white-coat hypertension syndrome: which is accompanied by target organ damage? , 2000, Archives of internal medicine.

[39]  C. Bulpitt,et al.  Response to Antihypertensive Therapy in Older Patients With Sustained and Nonsustained Systolic Hypertension , 2000, Circulation.

[40]  F. Mee,et al.  Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society , 2000, BMJ : British Medical Journal.

[41]  G. Parati,et al.  Attenuation of the "white-coat effect" by antihypertensive treatment and regression of target organ damage. , 2000, Hypertension.

[42]  G. Parati,et al.  Attenuation of the “ WhiteCoat Effect ” by Antihypertensive Treatment and Regression of Target Organ Damage , 2000 .

[43]  G. Mancia,et al.  Muscle and skin sympathetic nerve traffic during the "white-coat" effect. , 1999, Circulation.

[44]  J. Lekakis,et al.  Isolated clinic hypertension is not an innocent phenomenon: effect on the carotid artery structure. , 1999, American journal of hypertension.

[45]  R. Senior,et al.  Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. , 1998, Circulation.

[46]  E. O'Brien,et al.  Is elevation of clinic blood pressure in patients with white coat hypertension who have normal ambulatory blood pressure associated with target organ changes? , 1998, Journal of Human Hypertension.

[47]  H. Hense,et al.  Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey , 1998, BMJ.

[48]  R. Senior,et al.  Cardiovascular Outcome in WhiteCoat Versus Sustained Mild Hypertension A 10-Year Follow-Up Study , 1998 .

[49]  J. Reid,et al.  White-coat hypertension as a cause of cardiovascular dysfunction , 1996, The Lancet.

[50]  Sacchi,et al.  Identification of subjects with white-coat hypertension and persistently normal ambulatory blood pressure. , 1996, Blood pressure monitoring.

[51]  T. Pickering.  White coat hypertension. , 1996, Current opinion in nephrology and hypertension.

[52]  G. Schillaci,et al.  White-coat hypertension , 1996, The Lancet.

[53]  R. Herd,et al.  White coat effects , 1995, BMJ.

[54]  G. Schillaci,et al.  White coat hypertension and white coat effect. Similarities and differences. , 1995, American journal of hypertension.

[55]  M. Weber,et al.  Diagnosis of mild hypertension by ambulatory blood pressure monitoring. , 1994, Circulation.

[56]  J. Laragh,et al.  How common is white coat hypertension? , 1988, JAMA.

[57]  R. Watson,et al.  Variation in cuff blood pressure in untreated outpatients with mild hypertension--implications for initiating antihypertensive treatment. , 1987, Journal of hypertension.

[58]  J. Clarke,et al.  Mortality in patients of the Glasgow Blood Pressure Clinic. , 1986, Journal of hypertension.

[59]  Giuseppe Mancia,et al.  EFFECTS OF BLOOD-PRESSURE MEASUREMENT BY THE DOCTOR ON PATIENT'S BLOOD PRESSURE AND HEART RATE , 1983, The Lancet.